RT Bloomberg em Português (@BBGEmPortugues)O Fortitude Capital, fundo de private equity com aporte do BTG Pactual, já captou quase 500 milhões de euros para investir em estádios de futebol em Portugal https://t.co/ecNQERSt3p ...

Group 1 - The core viewpoint of the article is the establishment of the Zhongjin Yaosheng Mother Fund, which aims to leverage state-owned capital to promote the development of strategic emerging industries and achieve a win-win situation for industrial development and investment returns [1] - The Zhongjin Yaosheng Mother Fund has a total scale of 5 billion RMB and is focused on industries encouraged by the Shangyu district, including semiconductors, new materials, advanced manufacturing, medical and pharmaceutical, artificial intelligence, and new consumption [1] - The fund is open to soliciting high-quality sub-fund management institutions without restrictions on the registration location of the sub-funds [2]

Investment Opportunities in Sports - The sports industry presents a significant opportunity with an estimated $300-600 billion of value creation expected over the next decade [2] - Sports as an asset class is undergoing institutionalization, attracting venture capital, lower middle market buyout investors, and private equity firms [2] - The increasing sophistication and liquidity of previously illiquid private sports assets further enhance investment appeal [3] Challenges and Opportunities in Major League Baseball - Major League Baseball faces challenges including securing a national media package due to the decline of cable, achieving payroll parity, and resolving revenue sharing issues [4][5] - Resolving these challenges is expected to drive franchise values upward, similar to trends observed in the NBA [5] - Key metrics for evaluating baseball teams include market size, minor league system strength, player development, and stadium environment [6][7] Stadium Development and Revenue Generation - Building new stadiums, ballparks, and arenas is crucial for unlocking economic potential in sports, especially for facilities over 20 years old [9] - Modern stadiums should prioritize premium experiences, including multiple levels of club and suite products to cater to diverse market segments [11][12] - Developing sports-adjacent real estate, creating "live, work, play" environments around ballparks and arenas, represents a $1 trillion opportunity [13] - Diversifying revenue streams through real estate development allows teams to generate income 365 days a year, independent of league revenue sharing [14][35] Funding Models for Stadiums - Stadium funding models are evolving, with public-private partnerships remaining common due to the perceived value stadiums bring to cities [15][16] - Private capital is increasingly involved in stadium funding, particularly in areas where public funding is politically challenging [16] - The cost of building a new ballpark is approximately $2 billion [17] Ownership and Investment Structures - Sports team ownership is expanding beyond billionaires to include millionaires as minority owners [18] - Private equity funds are creating special purpose vehicles (SPVs) allowing retail investors to invest smaller amounts (e.g., $250,000 - $500,000) in sports teams [19] - While sports teams are less liquid than other asset classes, investing with experts in the secondary market can facilitate easier exits [21] Factors Driving Sales of Team Stakes - Owners may sell stakes to raise additional capital, capitalize on high valuations, or for estate planning purposes [25][26] - Limited partners (LPs) may also seek to sell their stakes to realize gains after holding them for a period [26][27] Media Rights and Future Growth - Media deals are a critical economic engine for sports franchises, driving profitability [30] - The future of broadcast rights is evolving with the rise of streaming and direct-to-consumer models, potentially diminishing the role of traditional broadcasters [39][40] - Leagues can continue to deliver growth through media packages and internationalization [37] - Local teams can unlock value by diversifying into media companies, park operations, and content creation [37][38]

Core Insights - ECGI Holdings Inc. has announced that its investment arm, Uplist Ventures, has become an affiliate member of TCA Venture Group, enhancing its access to a prominent angel investor network in the U.S. [1][4] - TCA Venture Group has invested over $280 million in 545 companies, which have collectively attracted an additional $2.1 billion in follow-on funding and achieved 126 exits, including 17 public listings [2] - The affiliation allows Uplist Ventures to access a curated pipeline of investment opportunities typically reserved for institutional investors, focusing on Series A and B startups [3][4] Company Strategy - The partnership with TCA is part of ECGI's strategy to align with respected players in the venture community, aiming to identify high-growth potential companies and explore pathways for future IPOs [4] - Uplist Ventures emphasizes disciplined growth and aims to strengthen its credibility within the venture and capital markets ecosystem [4] Investment Focus - ECGI, through Uplist Ventures, targets early-stage startups in sectors such as artificial intelligence, healthcare technology, blockchain, and vertical software [5] - Current investments include: - Payday Fantasy, which operates in the $89.9 billion global fantasy sports market [6] - TrueToForm, a patented AI-powered 3D body measurement SaaS in the $8.2 billion apparel fitting market [7] - Pacific Saddlery, a manufacturer in the $6.5 billion equestrian apparel market and the $11 billion equestrian equipment market [7] - Vintner's Caldera Ranch, a vineyard tapping into the $121 billion short-term rental market [8]

Investment Opportunity - Private equity firms struggling to realize returns may offer opportunities for distressed debt investors [1] Industry Analysis - Glendon Capital co-founder Holly Kim highlights the potential for distressed debt investors [1]

文：韦亚军 新加坡曹宝记（TPC）集团通过在华平台曹宝记（中国）企业管理有限公司出资0.6亿元，占14.63%， 为第二大LP。 施罗德资本则通过旗下海南三亚施罗德股权投资基金合伙企业（有限合伙）出资0.23亿元，占5.58%，为第三大LP。 通过出资结构，我们可以看出这是典型的"外资GP+境内机构LP"组合。 在过去的2年里，放眼中国一级市场，除了KKR，其他几乎能够叫得出名字的全球PE巨头，包括华平投资、汉领资本（Hamilton Lane）、路威凯腾（L Catterton）、施罗德资本、亚赋资本（Affirma Capital）、博枫（Brookfield）、以及黑石、凯雷、CVC等，都已经募集过或正在募集人民币基金。 摄影：Bob君 募集人民币基金，已经成为跨国PE们的新共识。 近日，KKR境内管理实体开德时璞（上海）私募投资基金合伙企业（有限合伙）在中国证券投资基金业协会完成备案，基金类型为私募股权基金。这标 志着KKR首支在岸人民币基金正式落地。 开德时璞成立于2024年12月，注册地在上海浦东，由KKR香港公司100%控股。 其中，平安资本通过旗下母基平台——金嘉兴平汇利海股权投资合伙企业（有 ...

Investment & Funding - L Catterton 领投 Flexjet 8 亿美元的股权投资 [1] Industry Trend - 全球对私人飞机旅行的需求持续激增 [1]

Core Insights - Lantheus (NASDAQ: LNTH) stock experienced a significant decline from $108 to $80 between January and May 2025, indicating volatility in its performance [1] Company Overview - MMMT Wealth, founded by Oliver, focuses on investment strategies and stock analysis, primarily in private equity, hedge funds, and asset management [1] - Oliver has 5 years of investing experience and 4 years as a CPA, emphasizing a long-term investment horizon of 3-5 years [1] Investment Philosophy - The company aims to gather insights from various sources, including investor calls, presentations, and financial reports, to form informed opinions on stocks [1] - Oliver's passion for investing is highlighted, with a belief that even a few successful investments can be life-changing [1]

Transaction Overview - CVC Capital Partners initiates refinancing of its sports assets portfolio [1] - The portfolio is valued at over £9 billion, equivalent to $12 billion [1]

Core Insights - Royalty Pharma plc has appointed Carole Ho and Elizabeth (Bess) Weatherman to its Board of Directors, enhancing its leadership team with expertise in biopharmaceuticals and finance [1][2][3] Group 1: Board Appointments - Carole Ho is the Chief Medical Officer and Head of Development at Denali Therapeutics, with 20 years of experience in biopharma, previously serving as Vice President of Clinical Development at Genentech [2][3] - Bess Weatherman has 35 years of experience as an investor in the healthcare industry and is currently a Special Limited Partner at Warburg Pincus, having joined the firm in 1988 [3] Group 2: Company Overview - Royalty Pharma, founded in 1996, is the largest buyer of biopharmaceutical royalties and a key funder of innovation in the biopharmaceutical sector, collaborating with various innovators [4] - The company has a portfolio that includes royalties on over 35 commercial products and 16 development-stage product candidates, indicating a strong position in the market [4] Group 3: Corporate Governance - The appointment of the new board members increases independent representation on the board to over 90%, reflecting Royalty Pharma's commitment to enhanced corporate governance [5]